are glp 1 safe for kidneys Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection GLP-1 Use in Non-Diabetics Associated
Description
Step 5: Use Backup Protection
They found that treatment with metformin in combination with GIMM resulted in lower fasting glucose levels, suggesting better tolerance of metformin therapy for longer or at a higher dosage
Faster protocols also mean less total time exposed to the gastrointestinal side effects that accompany all incretin therapies
FDA removes menopause hormone therapy black box warnings Experts implored the agency to balance the treatment's risks and benefits
